Injectable codeine is available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this can lead to nonimmune mast-mobile degranulation and ensuing anaphylactoid reaction. Codeine suppositories are also marketed in certain countries. In Eire, new rules arrived into impact on one August 2010[90] about codeine, as a consequence https://codeingil.com/